Company Overview and News

Hammond Power Solutions: Strong 2017, Mixed Q1 2018 And Yet A Step In The Right Direction

2018-05-21 seekingalpha
Last year was pretty strong for the Hammond Power Solutions (OTC:HMDPF) business with sales increasing in all markets except Italy. Sales in Canada were up 9% over the course of 2017, an annual growth not seen since 2012. In Q1 2018, sales continued to be strong, noting a 22% increase over the same quarter in 2017. We saw a similar picture in the U.S. sales and bookings, with revenue increasing by 12% over the FY 2017 and 11% in constant currency in Q1 2018 compared to Q1 2017.

EnSync's (ESNC) CEO Brad Hansen on Fiscal Q3 2018 Results - Earnings Call Transcript

2018-05-16 seekingalpha
Good afternoon, everyone, and welcome to EnSync Energy reports third quarter fiscal year 2018 results conference call. All participants will be in a listen-only mode. [Operator Instructions]. After today's presentation, there will be an opportunity to ask questions. [Operator Instructions]. Please also note today's event is also being recorded.

Regal Beloit (RBC) Q1 Earnings & Revenues Top, '18 View Up

2018-05-08 zacks
Regal Beloit Corporation (RBC - Free Report) reported decent first-quarter 2018 results, supported by strong organic sales growth and favorable foreign currency translation impact. On a GAAP basis, the industrial goods manufacturer reported net income of $58.4 million or $1.31 per share compared with $46.3 million or $1.02 per share in the year-earlier quarter. The year-over-year improvement was primarily due to higher revenues across segments.

UPDATE 1-China says will steadily push forward capital account convertibility

2018-05-04 reuters
BEIJING (Reuters) - China’s foreign exchange regulator said on Friday that it will steadily push forward with the convertibility of its capital account, and at the same time fend off risk from cross-border capital flows.

Control4 Corporation's (CTRL) CEO Martin Plaehn on Q1 2018 Results - Earnings Call Transcript

2018-05-04 seekingalpha
Good day, and welcome to the Control4 First Quarter Fiscal Year 2018 Earnings Conference Call. Today's call is being recorded.

Schneider Electric (SBGSY) To Buy Larsen & Toubro's Electrical & Automation business for €1.75B - S;ideshow

2018-05-03 seekingalpha
The following slide deck was published by Schneider Electric SE ADR in conjunction with this event.

L&T sells electrical arm to Schneider for Rs 14K cr

Mumbai : Engineering major Larsen & Toubro (L&T) on Tuesday sold its electrical and automation (E&A) business to the France giant Schneider Electric for Rs 14,000 crore in an all-cash deal.

L&T to sell its electric unit to Schneider for Rs14,000 crore

2018-05-01 livemint
Mumbai: Larsen & Toubro, India’s largest engineering and construction company, will sell its electrical and automation business to European multinational Schneider Electric for Rs14,000 crore. This is part of L&T’s stated move to prune non-core businesses. The deal is subject to receiving regulatory approvals.

LT to sell electrical automation biz to Schneider Electric for Rs 14K cr

2018-05-01 moneycontrol
India’s largest engineering and construction company Larsen & Toubro (L&T) has entered into a definitive agreement for divestment of its electrical and automation business to Schneider Electric for Rs 14,000 crore. The sale is expected to be completed within 18 months of signing the definitive documents, the company said in an exchange filling.

Tencent builds giant bomb shelter in this remote Chinese province to house WeChat data

2018-05-01 scmp
Many large technology companies – including Tencent, Alibaba, Foxconn and Apple – have shown strong support for Beijing’s goal to turn Guizhou province into a world-class hi-tech location

L&T is said to agree to sell unit to Schneider Electric for $2.1 billion

2018-04-30 livemint
Mumbai: Larsen & Toubro Ltd (L&T), India’s largest engineering and construction company, has agreed to sell its electrical unit to a consortium led by Schneider Electric SE, people with knowledge of the matter said.

Lazard Ltd Reports First-Quarter 2018 Results

2018-04-26 businesswire
“Our clients and our shareholders are benefitting from investments we’ve made in the business, and we continue to pursue opportunities for growth.”

Schneider Electric Still Not Getting Full Marks For Its Performance

2018-04-24 seekingalpha
Schneider delivered a surprisingly strong first quarter revenue number, with low voltage and industrial automation segments growing at 9% and overall organic growth of 6%.

Schneider Electric (SBGSY) Investor Presentation - Slideshow

2018-04-20 seekingalpha
The following slide deck was published by Schneider Electric SE ADR in conjunction with this event.

Recalls this week: electrical safety switches, toys

More than 1 million electrical safety switches are being recalled because of a faulty switch. Other recalled consumer products this week include toy xylophones, ski bindings, and decorative cushions.

Related Articles

ANTH: Anthera Pharmaceuticals Analysis and Research Report

23h - Asif

Overview Anthera Pharmaceuticals, Inc. is a biopharmaceutical company focused on advancing the development and commercialization of innovative medicines that benefit patients with unmet medical needs. The company currently have two compounds in development, Sollpura and blisibimod. The company licensed Sollpura from Eli Lilly & Co (“Eli Lilly”) in July 2014. Sollpura is a novel non-porcine investigational Pancreatic Enzyme Replacement Therapy (“PERT”) intended for the treatment of patients with Exocrine Pancreatic Insufficiency (“EPI”), often seen in patients with cystic fibrosis and other conditions. The company licensed blisibimod from Amgen, Inc. (“Amgen”) in December 2007. Blisibimod targets B-cell activating factor, or BAFF, which has been shown to be elevated in a variety of B-cell mediated autoimmune diseases, including Immunoglobulin A nephropathy, or IgA nephropathy. Sollpura The exocrine pancreas is responsible for synthesis and secretion of digestive en...

AGEN: Agenus Inc Analysis and Research Report

23h - Asif

Business Agenus is a clinical-stage immuno-oncology (“I-O”) company dedicated to becoming a leader in the discovery and development of innovative combination therapies and committed to bringing effective medicines to patients with cancer. The company's business is designed to drive success in I-O through speed, innovation, and effective combination therapies. Agenus has assembled fully integrated capabilities from novel target discovery, antibody generation, cell line development, and good manufacturing practice (“GMP”) manufacturing together with a comprehensive portfolio consisting of antibody-based therapeutics, adjuvants and cancer vaccine platforms. The company leverage its immune biology platforms to identify effective combination therapies for development and have developed productive partnerships to advance its innovation. The company believe the next generation of cancer treatment will build on clinically validated antibodies targeting CTLA-4 and PD-1 combined wi...

SQ: Square Analysis and Research Report

2018-05-21 - Asif

Business The company started Square in February 2009 to enable businesses (sellers) to accept card payments, an important capability that was previously inaccessible to many businesses. However, sellers also need innovative solutions to thrive, and Square has since expanded to provide additional products and services to give these businesses access to the same tools as large businesses. This approach aligns with its purpose of economic empowerment, as everything the company do should give sellers accessible, affordable tools to grow their businesses and participate in the economy. Square is a cohesive commerce ecosystem that helps its sellers start, run, and grow their businesses. The company combine sophisticated software with affordable hardware to enable sellers to turn mobile and computing devices into powerful payment and point-of-sale solutions. Square has high seller acceptance rates and fast onboarding, while maintaining low risk and fraud losses as a result of its a...